← Leaderboards
Erika Amy Tyburski
Sanguina, Llc
$2,770,903
Attributed
$3,555,136
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,555,136 · 2
By mechanism
R44$3,405,136 · 1
R43$150,000 · 1
Top collaborators
- Wilbur A Lam3 shared
Others in their field
Other Emerging Leaders on “Hematological Disease”
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Olwen Hahn · Brigham And Women'S Hospital$23,691,312
- Patricia Shifflett · Westat, Inc.$16,650,520
- Bronwen Shaw · Medical College Of Wisconsin$15,978,709
- Ashok Kumar Krishnamurthy · Univ Of North Carolina Chapel Hill$14,385,480
- Brandi Nicole Davis-Dusenbery · Children'S Hosp Of Philadelphia$8,885,000
Research focus
Hematological DiseaseImageDiagnostic TestsEtiologyHemoglobinHuman ResourcesCostDiagnosisCollaborationsEquipmentComplete Blood CountDiagnosticAnemiaHemoglobin Concentration ResultAffectClinical ResearchBedsCellular PhoneBloodChronicDevicesClinics And HospitalsCommunicationLife
Grant awards (5)
Translation of a personalized, non-invasive smartphone app for hemoglobin monitoring for chronic anemia patients$1,000,000
R44 · FY2025 · HL · contact PI
Translation of a personalized, non-invasive smartphone app for hemoglobin monitoring for chronic anemia patients$986,670
R44 · FY2024 · HL · contact PI
SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.$698,934
R44 · FY2022 · HL · contact PI
SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.$719,532
R44 · FY2021 · HL · contact PI
On-demand smartphone app for non-invasive anemia detection using only patient-sourced photos in low resource settings.$150,000
R43 · FY2019 · HL · contact PI